For advertising queries please email advertising@pharmaphorum.com or for further information visit our Advertise page
For editorial queries please email editorial@pharmaphorum.com or for further information visit our Contribute page
 |
 |
 |
 |
 |
Servier $210m bet on IDEAYA's uveal melanoma therapy darovasertib seems to have paid off, as a trial sets up regulatory filings later in 2026.
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines